The miss on EPS estimates could negatively impact investor sentiment in the short term, suggesting potential cost or operational inefficiencies. However, the beat on sales estimates and the year-over-year growth indicate strong demand for Exact Sciences' products and services, which could counterbalance the negative EPS impact. The mixed results lead to a neutral short-term price direction score, with the positive sales growth potentially mitigating concerns over the EPS miss.